Multicenter observational study of diagnostic test validation (Research Involving the Human Person, type 3) In addition to the diagnosis by the reference method (nasopharyngeal swab), the patient will be asked to provide a saliva sample via a salivary spit. The clinical circumstances of the diagnosis, the age of the patient, the associated terrain (diabetes, immunodepression, pregnancy) will be noted. The nasopharyngeal and saliva samples will be analyzed in Cayenne and the remaining samples will be frozen and stored at the CRB before being sent to the University Hospital of Caen for analysis and concordance verification. The expected benefits are: Possibility of repeating tests in the same person more easily due to the absence of pain and thus reduce the barriers to diagnosis and screening. Possibility of self-sampling, which could simply be sent to the laboratory, which would relieve the diagnostic sites that mobilize staff and require a fairly heavy organization. Avoid long waiting lines that can be an obstacle and lead to a renunciation of the diagnosis.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
1,159
Results of nasopharyngeal and salivary samples taken at the Cayenne hospital and the Caen university center, * Pre-analytical particularities and analytical particularities * Cycle threeshold * Demographic variables * Clinical variables * Clinical criteria * Questionnaire on the perception of the 2 sampling methods
General Hospital of Cayenne
Cayenne, French Guiana
Sensitivity of salivary test vs. nasopharyngeal test
Time frame: 1 day
- Proportion of analyses not performed on salivary samples for the following reasons (vs. number of salivary sample analyses performed): o Insufficient quantity of biological sample, o Inability to collect the sample
Time frame: 1 day
Perception of the tests by questionnaire (proportion of positive opinions)
Time frame: 1 day
Perception of the tests by questionnaire (proportion of negative opinions)
Time frame: 1 day
Positivity and negativity of the salivary test vs. symptomatology and associated terrain
Time frame: 1 day
Sensitivity and specificity analysis between the salivary test and the nasopharyngeal test according to the clinical context
Sensitivity and specificity analysis between the salivary test and the nasopharyngeal test according to the time between the samples and the onset of symptoms, the time between the samples and the contact with an index case, the known immunodepression and the clinical context (diabetes, pregnancy)
Time frame: 1 day
Description of the aspect of the saliva collected: mucous or fluid
Description of the analytical criteria of the saliva sample
Time frame: 1 day
Volume of saliva collected (mL)
Description of the analytical criteria of the saliva sample: (pipette measurement, if the saliva is not fluid, pipette measurement after vortexing for 1 min)
Time frame: 1 day
Description of the analytical criteria of the saliva sample:pre-analytical treatments if necessary
Time frame: 1 day
Number of Cycle threeshold for the first analysis (done at the Cayenne hospital) and the second analysis (done at the university hospital of Caen)
Time frame: 1 day
- Sensitivity of salivary test vs nasopharyngeal test with strong positives (3 genes detected)
Time frame: 1 day
- Specificity of salivary test vs nasopharyngeal test with strong positives (3 genes detected)
Time frame: 1 day
- Sensitivity of salivary test vs nasopharyngeal test with weak positives (1 gene detected)
Time frame: 1 day
- Specificity of salivary test vs nasopharyngeal test with weak positives (1 gene detected)
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.